Browse > Article

Prevention of Macrophage-Related Inflammatory Diseases by Allergina  

Han, Sang-B. (Korea Research Institute of Bioscience and Biotechnology (KRIBB))
Lee, Chang-W. (Korea Research Institute of Bioscience and Biotechnology (KRIBB))
Park, Song-K. (Korea Research Institute of Bioscience and Biotechnology (KRIBB))
Yoon, Won-K. (Korea Research Institute of Bioscience and Biotechnology (KRIBB))
Moon, Jae-S. (Korea Research Institute of Bioscience and Biotechnology (KRIBB))
Lee, Ki-H. (Korea Research Institute of Bioscience and Biotechnology (KRIBB))
Kim, Hyung-C. (Korea Research Institute of Bioscience and Biotechnology (KRIBB))
Kim, Hwan-M. (Korea Research Institute of Bioscience and Biotechnology (KRIBB))
Publication Information
Archives of Pharmacal Research / v.26, no.4, 2003 , pp. 312-316 More about this Journal
Abstract
The oriental herbal combination allergina has been shown to inhibit allergic inflammation. In the present study, we demonstrate that the oral administration of allergina markedly inhibits the progression of inflammatory diseases, such as graft-versus-host diseases (in the allogeneic bone marrow transplantation and the parent-into-F1 transplantation models), collagen-induced arthritis and sheep red blood cell-induced delayed type hypersensitivity. The immunosuppressive activity of allergina in vivo appears to be associated, at least in part, with the inhibition of tumor necrosis factor-a production. In conclusion, our results suggest that allergina could be useful as a immunosuppressive agent for the treatment of macrophage-related inflammatory disease.
Keywords
Allergina; Graft-versus-host diseases; Collagen-induced arthritis; Delayed type hypersensitivity;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Conway, J. G., Andrews, R. C., Beaudet, B., Bickett, D. M., Boncek, V., Brodie, T. A., Clark, R. L., Crumrine, R. C., Leenitzer, M. A., McDougald, D. L., Han, B., Hedeen, K., Lin, P., Milla, M., Moss, M., Pink, H., Rabinowitz, M. H., Tippin, T., Scates, P. W., Selph, J., Stimpson, S. A., Warner, J., and Becherer, J. D., Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases. J. Pharmacol. Exp. Ther., 298, 900-908 (2001)?⨀ᤀĀ胝?⨀ᤀĀ僥?⨀ऀĀꃍ?⨀Ā삽?⨀栀Ā䢄⨀؀Ā좄⨀਀Ā䢅⨀܀Ā夅돀聡ಗ⨀塨?⨀졫ಗ⨀ㄅ돐ಗ⨀쁖잖⨀࡬ಗ⨀अ덐ᡬಗ⨀ࠅ晵瑵牥〴 ㈰〹ⴱㄭㄳ섂돀⡝ಗ⨀塨?⨀ᣋ?⨀餂돐ꡖ잖⨀ꡖ잖⨀䃋?⨀㤀덀僋?⨀㠀᠀ࡿ⨀碥잖⨀㤂돐桧ಗ⨀?⨀?⨀뢥잖⨀䤉덐좥잖⨀䠉⠉Ā䖽ꡞ匈ĀĀĀ글ꠄ잖⨀Ā잖⨀ÿ✀䡪ಗ⨀ಗ⨀䄇䀀??㤇돀邱஗⨀塨?⨀联잖⨀쀴җ⨀餀덀뢱஗⨀頀偪ಗ⨀联잖⨀   PUBMED
2 Gorgun, G., Miller, K. B., and Foss, F. M., Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood, 100, 941-947 (2002)   DOI   ScienceOn
3 Han, S. B., Park, S. H., Jeon, Y. J., Kim, Y. K., Kim, H. M., and Yang, K. H., Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen- induced arthritis. J. Pharmacol. Exp. Ther., 299, 415-425 (2001)   PUBMED
4 Taylor, P. A., Friedman, T. M., Korngold, R., Noelle, R. J., and Blazar, B. R., Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell. Blood, 99, 4601-4609 (2002)   DOI   ScienceOn
5 Jeong, H. J., Hong, S. H., Kim, S. C., Park, E. J., Jang, C. H., Kim, K. S., and Kim, H. M., Effects of Allergina on the treatment of otitis media with effusions. Inflammation, 26, 89-95 (2002)   DOI   ScienceOn
6 Okamoto, I., Iwaki, K., Koya-Miyata, S., Tanimoto, T., Kohno, K., Ikeda, M., and Kurimoto, M., The flavonoid Kaempferol suppresses the graft-versus-host reaction by inhibiting type 1 cytokine production and CD8+ T cell engraftment. Clin. Immunol., 103, 132-144 (2002)   DOI   ScienceOn
7 Wagner, J. E., Donnenberg, A. D., Noga, S. J., Cremo, C. A., Gao, I. K., Yin, H. J., Vogelsang, G. B., Rowley, S., Saral, R., and Santos, G. W., Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial. Blood, 72, 1168-1176 (1988)   PUBMED
8 Weisdorf, D., Haake, R., Blazar, B., Miller, W., McGlave, P., Ramsay, N., Kersey, J., and Filipovich, A., Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome. Blood, 75, 1024-1030 (1990)   PUBMED
9 Lu, Y., Sakamaki, S., Kuroda, H., Kusakabe, T., Konuma, Y., Akiyama, T., Fujimi, A., Takemoto, N., Nishiie, K., Matsunaga, T., Hirayama, Y., Kato, J., Kon, S., Kogawa, K., and Niitsu, Y., Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603. Blood, 97, 1123-1130 (2001)   DOI   ScienceOn
10 Luross, J. A. and Williams, N. A., The genetic and immunopathological processes underlying collagen-induced arthritis. Immunol., 103, 407-416 (2001)   DOI   ScienceOn
11 Jeong, H. J., Jung, S. W., Kim, K. S., Lim, J. P., Park, E. J., Hwang, W. J., Jang, C. H., and Kim, H. M., Effect of allergina on mast cell-mediated allergic reactions. Immunopharmacol. Immunotoxicol., 23, 627-637 (2001)
12 Gongora, L., Manez, S., Giner, R. M., Recio, M. C., and Rios, J. L., On the activity of trifluoperazine and palmitoylcarnitine in mice: delayed hypersensitivity models. Life Sci., 66, L183-188 (2000)